SARS-CoV-2 is evolving with mutations in the receptor binding domain (RBD) being of
particular concern. It is important to know how much cross-protection is offered between strains …

In light of the COVID‐19 pandemic, there is an ongoing need for diagnostic tools to monitor
the immune status of large patient cohorts and the effectiveness of vaccination campaigns. …

Life-threatening thrombotic events at unusual sites have been reported after vector-based
vaccinations against severe acute respiratory syndrome coronavirus 2. This phenomenon is …

The advancement of new immunotherapies necessitates appropriate probes to monitor the
presence and distribution of distinct immune cell populations. Considering the key role of …

In biomedical research, there is an ongoing demand for new technologies to elucidate
disease mechanisms and develop novel therapeutics. This requires comprehensive …

The ongoing COVID‐19 pandemic and the emergence of new SARS‐CoV‐2 variants of
concern (VOCs) requires continued development of effective therapeutics. Recently, we …

The identification of diagnostic and therapeutic targets requires a comprehensive understanding
of cellular processes, for which advanced technologies in biomedical research are …

Background The rapid emergence of the Omicron variant and its large number of mutations
led to its classification as a variant of concern (VOC) by the World Health Organization. …

As global vaccination campaigns against SARS-CoV-2 proceed, there is particular interest
in the longevity of immune protection, especially with regard to increasingly infectious virus …

N-linked glycosylation is a ubiquitous posttranslational modification of proteins. While it plays
an important role in the biological function of proteins, it often poses a major challenge for …